Smart-Money SignalNeutral · 51/100— Insider open-market flow is flat over 90 days
Revenue$14.7M
Net Income$3.5M
EPS$0.61
Market Cap$113.4M
Price Performance
Historical data including institutional events
Company Profile
N
Nicholas Curtis
CEO & Executive Director
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.
The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room.
LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
